Lazzaro C - Search Results

1

[Economic evaluation of posaconazole in prophylaxis of invasive fungal infections in Italian neutropenic patients with acute myeloid leukaemia or myelodysplastic syndrome].

Lazzaro C. Lazzaro C. Infez Med. 2010 Jun;18(2):91-103. Infez Med. 2010. PMID: 20610931 Free article. Clinical Trial. Italian.

2

Economic evaluation of treating clinically isolated syndrome and subsequent multiple sclerosis with interferon beta-1b.

Lazzaro C, Bianchi C, Peracino L, Zacchetti P, Uccelli A. Lazzaro C, et al. Neurol Sci. 2009 Feb;30(1):21-31. doi: 10.1007/s10072-009-0015-0. Epub 2009 Jan 24. Neurol Sci. 2009. PMID: 19169625

3

Subcutaneous vs intravenous administration of immunoglobulin in chronic inflammatory demyelinating polyneuropathy: an Italian cost-minimization analysis.

Lazzaro C, Lopiano L, Cocito D. Lazzaro C, et al. Neurol Sci. 2014 Jul;35(7):1023-34. doi: 10.1007/s10072-014-1632-9. Epub 2014 Jan 28. Neurol Sci. 2014. PMID: 24469345 Free article.

4

An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) + gemcitabine vs gemcitabine alone for metastatic pancreatic cancer patients: the APICE study.

Lazzaro C, Barone C, Caprioni F, Cascinu S, Falcone A, Maiello E, Milella M, Pinto C, Reni M, Tortora G. Lazzaro C, et al. Expert Rev Pharmacoecon Outcomes Res. 2018 Aug;18(4):435-446. doi: 10.1080/14737167.2018.1464394. Epub 2018 Apr 20. Expert Rev Pharmacoecon Outcomes Res. 2018. PMID: 29641931

5

Tacrolimus versus cyclosporin in renal transplantation in Italy: cost-minimisation and cost-effectiveness analyses.

Lazzaro C, McKechnie T, McKenna M. Lazzaro C, et al. J Nephrol. 2002 Sep-Oct;15(5):580-8. J Nephrol. 2002. PMID: 12455727 Clinical Trial.

6

An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study.

Lazzaro C, Bordonaro R, Cognetti F, Fabi A, De Placido S, Arpino G, Marchetti P, Botticelli A, Pronzato P, Martelli E. Lazzaro C, et al. Clinicoecon Outcomes Res. 2013 Apr 11;5:125-35. doi: 10.2147/CEOR.S41850. Print 2013. Clinicoecon Outcomes Res. 2013. PMID: 23610525 Free PMC article.

7

Healthcare costs of the SATisfaction and adherence to COPD treatment (SAT) study follow-up.

Corsico AG, Braido F, Contoli M, Di Marco F, Rogliani P, Scognamillo C, Olivi I, Santus P, Scichilone N, Lazzaro C. Corsico AG, et al. Among authors: lazzaro c. Respir Med. 2019 Jul;153:68-75. doi: 10.1016/j.rmed.2019.05.017. Epub 2019 May 29. Respir Med. 2019. PMID: 31174106 Free article. Clinical Trial.

8

AbobotulinumtoxinA and rehabilitation vs rehabilitation alone in post-stroke spasticity: A cost-utility analysis.

Lazzaro C, Baricich A, Picelli A, Caglioni PM, Ratti M, Santamato A. Lazzaro C, et al. J Rehabil Med. 2020 Feb 7;52(2):jrm00016. doi: 10.2340/16501977-2636. J Rehabil Med. 2020. PMID: 31820010 Free article.

9

Principal-agent theory-based cost and reimbursement structures of isavuconazole treatment in German hospitals.

Kron F, Wingen-Heimann SM, Jeck J, Lazzaro C, Cornely OA, Thielscher C. Kron F, et al. Among authors: lazzaro c. Mycoses. 2021 Jan;64(1):86-94. doi: 10.1111/myc.13192. Epub 2020 Oct 15. Mycoses. 2021. PMID: 33034927

10

Chemotherapy-based versus chemotherapy-free stem cell mobilization (± plerixafor) in multiple myeloma patients: an Italian cost-effectiveness analysis.

Lazzaro C, Castagna L, Lanza F, Laszlo D, Milone G, Pierelli L, Saccardi R. Lazzaro C, et al. Bone Marrow Transplant. 2021 Aug;56(8):1876-1887. doi: 10.1038/s41409-021-01251-8. Epub 2021 Mar 22. Bone Marrow Transplant. 2021. PMID: 33753907 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters